A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms

Atherosclerosis

Volumn 261, Issue , 2017, Pages 78-89

  Iyer, Vikram ^a,b,c   Rowbotham, Sophie ^a,c   Biros, Erik ^c   Bingley, John ^a   Golledge, Jonathan ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

Abdominal aortic aneurysm; Epigenetics; microRNA

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 223; MICRORNA 24; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; CIRCULATING MICRORNA;

ABDOMINAL AORTIC ANEURYSM; AORTIC TISSUE; CARDIOVASCULAR RISK; EPIGENETICS; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ANIMAL; AREA UNDER THE CURVE; BLOOD; DISEASE EXACERBATION; GENETIC EPIGENESIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; AREA UNDER CURVE; CIRCULATING MICRORNA; DISEASE PROGRESSION; EPIGENESIS, GENETIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 85017124652     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.03.010     Document Type: Review

References (44)

1. Aggarwal, S., Qamar, A., Sharma, V., Sharma, A., Abdominal aortic aneurysm: a comprehensive review. Exp. Clin. Cardiol. 16:1 (2011), 11–15.
2. Golledge, J., Muller, J., Daugherty, A., Norman, P., Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 26:12 (2006), 2605–2613.
3. Golledge, J., Norman, P.E., Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management. Curr. Opin. Cardiol. 24:6 (2009), 532–538.
4. Golledge, J., Norman, P.E., Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 217:1 (2011), 57–63.
5. Anderson, J.L., et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American college of cardiology foundation/American Heart association task force on Practice guidelines. Circulation 127:13 (2013), 1425–1443.
6. Rooke, T.W., et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American college of cardiology foundation/American Heart association task force on Practice guidelines. J. Am. Coll. Cardiol. 61:14 (2013), 1555–1570.
7. Lederle, F.A., et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm detection and management (ADAM) veterans affairs cooperative study group. Ann. Intern Med. 126:6 (1997), 441–449.
8. Moxon, J.V., Parr, A., Emeto, T.I., Walker, P., Norman, P.E., Golledge, J., Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr. Probl. Cardiol. 35:10 (2010), 512–548.
9. Singh, K., Bonaa, K.H., Jacobsen, B.K., Bjork, L., Solberg, S., Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the tromso study. Am. J. Epidemiol. 154:3 (2001), 236–244.
10. Blanchard, J.F., Armenian, H.K., Friesen, P.P., Risk factors for abdominal aortic aneurysm: results of a case-control study. Am. J. Epidemiol. 151:6 (2000), 575–583.
11. Lindholt, J.S., Sorensen, H.T., Michel, J.B., Thomsen, H.F., Henneberg, E.W., Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc. Endovasc. Surg. 42:4 (2008), 329–334.
12. Demirpolat, G., Ozturk, N., Parildar, M., Posacioglu, H., Tamsel, S., Duplex ultrasound evaluation of endoluminally treated aortic aneurysms with emphasis on diameter measurement: a comparison with computed tomography. J. Clin. Ultrasound. 39:5 (2011), 263–269.
13. Fillinger, M.F., et al. Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: implications for rupture risk. J. Vasc. Surg. 39:6 (2004), 1243–1252.
14. Hinchliffe, R.J., et al. Comparison of morphologic features of intact and ruptured aneurysms of infrarenal abdominal aorta. J. Vasc. Surg. 38:1 (2003), 88–92.
15. Rakita, D., Newatia, A., Hines, J.J., Siegel, D.N., Friedman, B., Spectrum of CT findings in rupture and impending rupture of abdominal aortic aneurysms. Radiographics 27:2 (2007), 497–507.
16. Siegel, C.L., Cohan, R.H., Korobkin, M., Alpern, M.B., Courneya, D.L., Leder, R.A., Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. AJR Am. J. Roentgenol. 163:5 (1994), 1123–1129.
17. Golledge, J., Kuivaniemi, H., Genetics of abdominal aortic aneurysm. Curr. Opin. Cardiol. 28:3 (2013), 290–296.
18. Golledge, J., Biros, E., Bingley, J., Iyer, V., Krishna, S.M., Epigenetics and peripheral artery disease. Curr. Atheroscler. Rep., 18(4), 2016, 15.
19. Farh, K.K., et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310:5755 (2005), 1817–1821.
20. Maegdefessel, L., The emerging role of microRNAs in cardiovascular disease. J. Intern Med. 276:6 (2014), 633–644.
21. Maegdefessel, L., et al. Micromanaging abdominal aortic aneurysms. Int. J. Mol. Sci. 14:7 (2013), 14374–14394.
22. Pasquinelli, A.E., Hunter, S., Bracht, J., MicroRNAs: a developing story. Curr. Opin. Genet. Dev. 15:2 (2005), 200–205.
23. Mitchell, P.S., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105:30 (2008), 10513–10518.
24. Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:1 (2009), 92–105.
25. Maegdefessel, L., Dalman, R.L., Tsao, P.S., Pathogenesis of abdominal aortic aneurysms: microRNAs, proteases, genetic associations. Annu. Rev. Med. 65 (2014), 49–62.
26. Biros, E., et al. microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clin. Sci. 126:11 (2014), 795–803.
27. Busch, A., et al. Aneurysm miRNA signature differs, depending on disease localization and morphology. Int. J. Mol. Sci., 17(1), 2016, E81.
28. Cheuk, B.L., Cheng, S.W., Identification and characterization of microRNAs in vascular smooth muscle cells from patients with abdominal aortic aneurysms. J. Vasc. Surg. 59:1 (2014), 202–209.
29. Kim, C.W., et al. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler. Thromb. Vasc. Biol. 34:7 (2014), 1412–1421.
30. Kin, K., et al. Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc., 1(5), 2012, e000745.
31. Licholai, S., et al. miR-29c-3p is an effective biomarker of abdominal aortic aneurysm in patients undergoing elective surgery. Microrna 5:2 (2016), 124–131.
32. Maegdefessel, L., et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci. Transl. Med., 4(122), 2012 122ra22.
33. Maegdefessel, L., et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J. Clin. Invest. 122:2 (2012), 497–506.
34. Maegdefessel, L., et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat. Commun., 5, 2014, 5214.
35. Pahl, M.C., et al. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med. Genomics., 5, 2012, 25.
36. Spear, R., et al. Adventitial tertiary lymphoid organs as potential source of microRNA biomarkers for abdominal aortic aneurysm. Int. J. Mol. Sci. 16:5 (2015), 11276–11293.
37. Stather, P.W., et al. Identification of microRNAs associated with abdominal aortic aneurysms and peripheral arterial disease. Br. J. Surg. 102:7 (2015), 755–766.
38. Wanhainen, A., et al. Screening of circulating microRNA biomarkers for prevalence of abdominal aortic aneurysm and aneurysm growth. Atherosclerosis 256 (2017), 82–88.
39. Zampetaki, A., et al. Role of miR-195 in aortic aneurysmal disease. Circ. Res. 115:10 (2014), 857–866.
40. Zhang, W., et al. Plasma microRNAs serve as potential biomarkers for abdominal aortic aneurysm. Clin. Biochem. 48:15 (2015), 988–992.
41. Folkesson, M., et al. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb. Haemost. 98:2 (2007), 427–433.
42. Wassef, M., et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the national heart, lung, and blood institute. J. Vasc. Surg. 34:4 (2001), 730–738.
43. Boon, R.A., et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 109:10 (2011), 1115–1119.
44. Christopher, A.F., et al. MicroRNA therapeutics: discovering novel targets and developing specific therapy. Perspect. Clin. Res. 8:2 (2016), 68–74.